Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML; International Workshop on Primary Hyperparathyroidism.
J Bone Miner Res. 2022 Nov;37(11):2293-2314. doi: 10.1002/jbmr.4677. Epub 2022 Oct 17.
Normocalcemic primary hyperparathyroidism.
Cusano NE, Cetani F.
Arch Endocrinol Metab. 2022 Nov 11;66(5):666-677. doi: 10.20945/2359-3997000000556.
Primary hyperparathyroidism.
Walker MD, Silverberg SJ.
Nat Rev Endocrinol. 2018 Feb;14(2):115-125. doi: 10.1038/nrendo.2017.104. Epub 2017 Sep 8.
Primary hyperparathyroidism.
Silva BC, Cusano NE, Bilezikian JP.
Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101247. doi: 10.1016/j.beem.2018.09.013. Epub 2018 Sep 28.
Primary Hyperparathyroidism.
Bilezikian JP.
J Clin Endocrinol Metab. 2018 Nov 1;103(11):3993-4004. doi: 10.1210/jc.2018-01225.
Primary hyperparathyroidism.
Oberger Marques JV, Moreira CA.
Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101514. doi: 10.1016/j.berh.2020.101514. Epub 2020 Apr 23.
Management of Primary Hyperparathyroidism.
Bilezikian JP, Silverberg SJ, Bandeira F, Cetani F, Chandran M, Cusano NE, Ebeling PR, Formenti AM, Frost M, Gosnell J, Lewiecki EM, Singer FR, Gittoes N, Khan AA, Marcocci C, Rejnmark L, Ye Z, Guyatt G, Potts JT.
J Bone Miner Res. 2022 Nov;37(11):2391-2403. doi: 10.1002/jbmr.4682. Epub 2022 Oct 17.
Primary hyperparathyroidism.
Silva BC, Cusano NE, Bilezikian JP.
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):593-607. doi: 10.1016/j.beem.2018.09.004. Epub 2018 Sep 22.
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.
Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP.
Osteoporos Int. 2017 Jan;28(1):1-19. doi: 10.1007/s00198-016-3716-2. Epub 2016 Sep 9.
Denosumab for osteoporosis in patients with primary hyperparathyroidism and mild-to-moderate renal insufficiency.
Gronskaya S, Belaya Z, Rozhinskaya L, Mamedova E, Vorontsova M, Solodovnikov A, Golounina O, Melnichenko G.
Endocrine. 2023 Aug;81(2):368-378. doi: 10.1007/s12020-023-03381-z. Epub 2023 May 3.
